City

Clinical trials near London, Canada

Active studies with a listed research site in London, Canada.

17active studies

8recruiting now

26countries represented

1,498largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 3

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Ulcerative Colitis, Obesity or OverweightCondition

Mirikizumab, MirikizumabTreatment

Austria, Belgium187 locations

Eli Lilly and CompanySponsor

Updated 2026-09-04 · NCT06937086See eligibility →

Recruiting nowPhase 3

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Crohn's Disease, Obesity or OverweightCondition

Mirikizumab, MirikizumabTreatment

Austria, Belgium183 locations

Eli Lilly and CompanySponsor

Updated 2026-09-04 · NCT06937099See eligibility →

Recruiting nowPhase 2

A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight

Obesity, OverweightCondition

BI 3034701, Placebo matching BI 3034701Treatment

Australia, Canada54 locations

Boehringer IngelheimSponsor

Updated 2026-09-03 · NCT07662122See eligibility →

Recruiting nowPhase 2

A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)

Overweight, ObesityCondition

PF-08653945, PF-08653944Treatment

Canada, United States65 locations

PfizerSponsor

Updated 2026-08-17 · NCT07575932See eligibility →

Recruiting nowPhase 3

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

ObesityCondition

NNC0487-0111, Placebo (matched to NNC0487-0111)Treatment

Argentina, Australia72 locations

Novo Nordisk A/SSponsor

Updated 2026-07-09 · NCT07339423See eligibility →

Recruiting nowPhase 4

Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2

Obesity, Chronic Kidney DiseaseCondition

Semaglutide, Virtual Weight Management CoachingTreatment

Canada1 locations

Western University, CanadaSponsor

Updated 2026-06-29 · NCT06396416See eligibility →

Recruiting nowNot applicable

A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes

Prediabetes / Type 2 DiabetesCondition

AMPK Charge+®, AMPK Charge+® with semaglutideTreatment

Canada1 locations

QuickSilver ScientificSponsor

Updated 2026-03-16 · NCT07195994See eligibility →

Recruiting nowEarly Phase 1

Akkermansia Muciniphilia and Metabolic Side Effects of ADT

Prostate Cancer, Metabolic SyndromeCondition

Apple Cider VinegarTreatment

Canada1 locations

Western UniversitySponsor

Updated 2025-08-20 · NCT05802121See eligibility →

Opening soonPhase 4

Exercise and Diabetes Interventions to Improve Brain Health in Older Adults With Type 2 Diabetes

Type 2 Diabetes, Cognitive Decline in Older AdultsCondition

semaglutide, Moderate-Intensity Resistance ExerciseTreatment

Canada1 locations

Western University, CanadaSponsor

Updated 2026-08-20 · NCT07485062See eligibility →

Opening soonNot applicable

A Two-part Study of Lembas Edge Evaluating Tolerability and Postprandial Glycemic Control

Postprandial Glycemic Control, Prediabetic Overweight and Obese AdultsCondition

Low dose alpha-galactosidase-derived peptide, Medium dose alpha-galactosidase-derived peptideTreatment

Canada1 locations

LembasSponsor

Updated 2026-07-17 · NCT07711288See eligibility →

Opening soonNot applicable

Trauma Therapy for Weight-Based Bullying in Children

Pediatric Obesity, Weight-based BullyingCondition

Trauma Therapy for Weight-Based Bullying Informed by TF-CBTTreatment

Canada1 locations

Western UniversitySponsor

Updated 2026-07-06 · NCT07685990See eligibility →

Opening soonNot applicable

A Clinical Trial to Investigate the Safety and Efficacy of MB-1 on Metabolic Health in Overweight and Obese Adults

Obese, Overweight AdultsCondition

MB-1, PlaceboTreatment

Canada1 locations

ArraeSponsor

Updated 2026-06-30 · NCT07363148See eligibility →

Active, not recruitingPhase 3

Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide

Overweight, ObesityCondition

Cagrilintide, Placebo (matched to Cagrilintide)Treatment

Argentina, Canada67 locations

Novo Nordisk A/SSponsor

Updated 2026-09-04 · NCT07220759See eligibility →

Active, not recruitingPhase 3

Breast Cancer WEight Loss Study (BWEL Study)

Breast Ductal Carcinoma In Situ, Invasive Breast CarcinomaCondition

Health Education Program, Weight Loss InterventionTreatment

Canada, Guam1,498 locations

Alliance for Clinical Trials in OncologySponsor

Updated 2026-09-02 · NCT02750826See eligibility →

Active, not recruitingPhase 3

Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide

Obesity, OverweightCondition

Cagrilintide, PlaceboTreatment

Argentina, Australia40 locations

Novo Nordisk A/SSponsor

Updated 2026-08-06 · NCT07220642See eligibility →

Active, not recruitingPhase 3

A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight

Obesity, OverweightCondition

RetatrutideTreatment

Argentina, Canada35 locations

Eli Lilly and CompanySponsor

Updated 2026-06-09 · NCT07357415See eligibility →

Active, not recruitingPhase 3

Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

Type 2 Diabetes Mellitus (T2DM), Obesity, OverweightCondition

Maridebart cafraglutide, PlaceboTreatment

Argentina, Bulgaria187 locations

AmgenSponsor

Updated 2025-12-31 · NCT06858878See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.

Clinical trials near London, Canada

Current studies

Related cities